CLINICAL_TRIALS
trial_result
· 2022-03-14
Clinical Trial Update: A Study of TD-9855 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD) [Phase 2]
Summary
Phase 2 clinical trial of TD-9855 in adults with ADHD has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Theravance Biopharma | Conditions: Attention-Deficit/Hyperactivity Disorder, ADHD | Phase 2 | Status: COMPLETED | Results posted: 2022-03-14